Company: ZLAB
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0001704292-25-000024
Chunk: 46

Company: Zai Lab Ltd
Filing Date: 2025-11-06
Form: 10-Q
Item: Part I, Item 1
Chunk 46
---
 Hytrulo27,727 27,265 72,329 63,617 NUZYRA15,430 9,997 44,840 32,205 OPTUNE12,657 7,715 36,375 32,779 QINLOCK8,901 8,643 25,946 21,774 XACDURO6,445 — 12,184 — AUGTYRO1,677 — 4,702 — Other (i)92 — 717 — Product revenue - net115,361 101,847 330,095 289,102 (i)Other includes product candidates sold in patient programs prior to commercialization. Collaboration Revenue Collaboration revenue was $0.7 million and $2.5 million in the three and nine months ended September 30, 2025, respectively, and $0.4 million and $0.8 million in the three and nine months ended September 30, 2024, respectively, and related to promotional activities in mainland China.

11

Zai Lab Limited Notes to the unaudited condensed consolidated financial statements 

8. Income Tax 

No provision for income taxes has been accrued because the Company is in a cumulative loss position for the periods presented. The Company recorded a full valuation allowance against deferred tax assets of all its consolidated entities because all entities were in a cumulative loss position as of September 30, 2025 and December 31, 2024. No unrecognized tax benefits and related interest and penalties were recorded in the periods presented.

9. Loss Per Share 

The following table presents the computation of the basic and diluted net loss per share ($ in thousands, except share and per share data):Three Months Ended September 30,Nine Months Ended September 30,2025202420252024Numerator:Net loss (35,963)(41,671)(125,128)(175,419)Denominator:Weighted-average number of ordinary shares - basic and diluted1,102,072,680 981,687,390 1,091,690,340 976,941,030 Net loss per share - basic and diluted(0.03)(0.04)(0.11)(0.18)As a result of the Company’s net loss in the three and nine months ended September 30, 2025 and 2024, share options and non-vested restricted shares outstanding in the respective periods were